Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG for Sepsis Prevention in Pediatric Burn Patients
NCT05134792Phase 3Completed
- Sponsor
- Cairo University
- Start
- Oct 2021
- Primary completion
- Jul 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of intravenous immunoglobulin G in sepsis, sponsored by Cairo University. Started Oct 2021; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT05134792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05134792.